Salient Capital Advisors’s Calumet Specialty Products CLMT Stock Holding History

Salient Capital Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-131,614	Closed	-$981K	–	59
2018 Q2	$981K	Buy	+131,614	New	+$989K	0.02%	58
2016 Q2	–	Sell	-397,872	Closed	-$4.67M	–	253
2016 Q1	$4.67M	Buy	397,872 +31,700	+9%	+$441K	0.13%	67
2015 Q4	$7.29M	Buy	366,172 +21,459	+6%	+$530K	0.19%	61
2015 Q3	$8.37M	Sell	344,713 -12,344	-3%	-$321K	0.2%	56
2015 Q2	$9.09M	Sell	357,057 -115,775	-24%	-$3.07M	0.17%	58
2015 Q1	$11.4M	Buy	472,832 +407,831	+627%	+$10.3M	0.21%	50
2014 Q4	$1.46M	Buy	+65,001	New	+$1.69M	0.03%	131

Other funds holding CLMT

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WWM

Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return

Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Salient Capital Advisors's CLMT Position: Q3 2018 in Review

Salient Capital Advisors sold out of Calumet Specialty Products (CLMT) in Q3 2018, closing a stake of 131,614 shares — an estimated $981K sold.

Salient Capital Advisors first reported a position in CLMT in Q4 2014 and held it in 7 quarters. The position peaked at $11.4M in Q1 2015. 68 funds tracked by Wall St. Rank hold CLMT as of Q3 2018.

Salient Capital Advisors reported no remaining Calumet Specialty Products position as of Q3 2018 after selling out during the quarter.
Salient Capital Advisors sold 131,614 Calumet Specialty Products shares in Q3 2018, an estimated $981K.
Salient Capital Advisors first reported a position in Calumet Specialty Products in Q4 2014 and held it in 7 quarters.
Salient Capital Advisors's Calumet Specialty Products position peaked at $11.4M in Q1 2015.
68 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2018.

Based on Salient Capital Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.